nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—Flatulence—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Clindamycin—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Clindamycin—Asthenia—Pentoxifylline—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Clindamycin—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Clindamycin—Erythema multiforme—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Clindamycin—Skin exfoliation—Methotrexate—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Clindamycin—Hypotension—Captopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Clindamycin—Pruritus—Pentoxifylline—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Clindamycin—Anaemia—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Clindamycin—Back pain—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Clindamycin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Clindamycin—Vaginal infection—Methotrexate—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Clindamycin—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Clindamycin—Flushing—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Clindamycin—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Clindamycin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Clindamycin—Vertigo—Leflunomide—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Clindamycin—Leukopenia—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Clindamycin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Clindamycin—Abdominal pain—Mometasone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Clindamycin—Body temperature increased—Mometasone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Clindamycin—Discomfort—Azathioprine—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Clindamycin—Dyspnoea—Captopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Clindamycin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Clindamycin—Dyspepsia—Captopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Clindamycin—Dizziness—Pentoxifylline—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Clindamycin—Hypertension—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Clindamycin—Erythema—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Clindamycin—Vertigo—Mycophenolic acid—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Clindamycin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Clindamycin—Fatigue—Captopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Clindamycin—Constipation—Captopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Clindamycin—Flatulence—Lisinopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Clindamycin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Clindamycin—Dysgeusia—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Clindamycin—Discomfort—Leflunomide—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Clindamycin—Back pain—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Clindamycin—Vomiting—Pentoxifylline—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Clindamycin—Muscle spasms—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Clindamycin—Rash—Pentoxifylline—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Clindamycin—Hypertension—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Clindamycin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Clindamycin—Headache—Pentoxifylline—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Clindamycin—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Clindamycin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Clindamycin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Clindamycin—Asthenia—Mometasone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Clindamycin—Hypotension—Azathioprine—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Clindamycin—Cardiac arrest—Prednisone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Clindamycin—Discomfort—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Clindamycin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Clindamycin—Pruritus—Mometasone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Clindamycin—Anaemia—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Clindamycin—Abdominal pain—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Clindamycin—Body temperature increased—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Clindamycin—Dry skin—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Clindamycin—Nausea—Pentoxifylline—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Clindamycin—Vertigo—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Clindamycin—Diarrhoea—Mometasone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Clindamycin—Leukopenia—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Clindamycin—Hypotension—Leflunomide—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Clindamycin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Clindamycin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Clindamycin—Abdominal distension—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Clindamycin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Clindamycin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Clindamycin—Dyspnoea—Leflunomide—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Clindamycin—Hypotension—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Clindamycin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Clindamycin—Discomfort—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Clindamycin—Dyspepsia—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Clindamycin—Vomiting—Mometasone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Clindamycin—Rash—Mometasone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Clindamycin—Asthenia—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Clindamycin—Dermatitis—Mometasone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Clindamycin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Clindamycin—Headache—Mometasone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Clindamycin—Fatigue—Leflunomide—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Clindamycin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Clindamycin—Pruritus—Captopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Clindamycin—Constipation—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Clindamycin—Pain—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Clindamycin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Clindamycin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Clindamycin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Clindamycin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Clindamycin—Neutropenia—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Clindamycin—Body temperature increased—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Clindamycin—Abdominal pain—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Clindamycin—Diarrhoea—Captopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Clindamycin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Clindamycin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Clindamycin—Fatigue—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Clindamycin—Nausea—Mometasone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Clindamycin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Clindamycin—Pain—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Clindamycin—Constipation—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Clindamycin—Hypotension—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Clindamycin—Dizziness—Captopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Clindamycin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Clindamycin—Urticaria—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Clindamycin—Body temperature increased—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Clindamycin—Abdominal pain—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Clindamycin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Clindamycin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Clindamycin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Clindamycin—Vomiting—Captopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Clindamycin—Dyspnoea—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Clindamycin—Rash—Captopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Clindamycin—Dermatitis—Captopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Clindamycin—Headache—Captopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Clindamycin—Dyspepsia—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Clindamycin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Clindamycin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Clindamycin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Clindamycin—Eosinophilia—Methotrexate—systemic scleroderma	0.000996	0.000996	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Clindamycin—Fatigue—Lisinopril—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Clindamycin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Clindamycin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Clindamycin—Constipation—Lisinopril—systemic scleroderma	0.000985	0.000985	CcSEcCtD
Clindamycin—Pain—Lisinopril—systemic scleroderma	0.000985	0.000985	CcSEcCtD
Clindamycin—Diarrhoea—Azathioprine—systemic scleroderma	0.000971	0.000971	CcSEcCtD
Clindamycin—Nausea—Captopril—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Clindamycin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Clindamycin—Asthenia—Leflunomide—systemic scleroderma	0.000962	0.000962	CcSEcCtD
Clindamycin—Pruritus—Leflunomide—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Clindamycin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Clindamycin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000942	0.000942	CcSEcCtD
Clindamycin—Dysuria—Methotrexate—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Clindamycin—Neutropenia—Methotrexate—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Clindamycin—Dizziness—Azathioprine—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000934	0.000934	CcSEcCtD
Clindamycin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Clindamycin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Clindamycin—Diarrhoea—Leflunomide—systemic scleroderma	0.000917	0.000917	CcSEcCtD
Clindamycin—Urticaria—Lisinopril—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Clindamycin—Abdominal pain—Lisinopril—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Clindamycin—Body temperature increased—Lisinopril—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Clindamycin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000905	0.000905	CcSEcCtD
Clindamycin—Vomiting—Azathioprine—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Clindamycin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Clindamycin—Rash—Azathioprine—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Clindamycin—Dermatitis—Azathioprine—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Clindamycin—Flushing—Prednisone—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Clindamycin—Headache—Azathioprine—systemic scleroderma	0.000889	0.000889	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000889	0.000889	CcSEcCtD
Clindamycin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Clindamycin—Dizziness—Leflunomide—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Clindamycin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Clindamycin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Clindamycin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Clindamycin—Vomiting—Leflunomide—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Clindamycin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Clindamycin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Clindamycin—Epistaxis—Methotrexate—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Clindamycin—Rash—Leflunomide—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Clindamycin—Dermatitis—Leflunomide—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Clindamycin—Nausea—Azathioprine—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Clindamycin—Headache—Leflunomide—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Clindamycin—Erythema—Prednisone—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Clindamycin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Clindamycin—Asthenia—Lisinopril—systemic scleroderma	0.000827	0.000827	CcSEcCtD
Clindamycin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Clindamycin—Pruritus—Lisinopril—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Clindamycin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Clindamycin—Rash—Mycophenolic acid—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Clindamycin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Clindamycin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Clindamycin—Headache—Mycophenolic acid—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Clindamycin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Clindamycin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Clindamycin—Nausea—Leflunomide—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Clindamycin—Diarrhoea—Lisinopril—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Clindamycin—Anaemia—Prednisone—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Clindamycin—Dizziness—Lisinopril—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Clindamycin—Nausea—Mycophenolic acid—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Clindamycin—Vertigo—Prednisone—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Clindamycin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Clindamycin—Vomiting—Lisinopril—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Clindamycin—Rash—Lisinopril—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Clindamycin—Dermatitis—Lisinopril—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Clindamycin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Clindamycin—Hypertension—Prednisone—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Clindamycin—Headache—Lisinopril—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Clindamycin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Clindamycin—Discomfort—Prednisone—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Clindamycin—Erythema—Methotrexate—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Clindamycin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000691	0.000691	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Clindamycin—Nausea—Lisinopril—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Clindamycin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Clindamycin—Back pain—Methotrexate—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Clindamycin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Clindamycin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Clindamycin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Clindamycin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Clindamycin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Clindamycin—Dyspepsia—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Clindamycin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Clindamycin—Fatigue—Prednisone—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Clindamycin—Constipation—Prednisone—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Clindamycin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000572	0.000572	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Clindamycin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Clindamycin—Urticaria—Prednisone—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Clindamycin—Body temperature increased—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Clindamycin—Abdominal pain—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Clindamycin—Hypersensitivity—Prednisone—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Clindamycin—Dyspepsia—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Clindamycin—Asthenia—Prednisone—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Clindamycin—Pain—Methotrexate—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Clindamycin—Pruritus—Prednisone—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Clindamycin—Diarrhoea—Prednisone—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Clindamycin—Urticaria—Methotrexate—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Clindamycin—Dizziness—Prednisone—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Clindamycin—Abdominal pain—Methotrexate—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Clindamycin—Vomiting—Prednisone—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Clindamycin—Rash—Prednisone—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Clindamycin—Dermatitis—Prednisone—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Clindamycin—Headache—Prednisone—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Clindamycin—Asthenia—Methotrexate—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Clindamycin—Nausea—Prednisone—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Clindamycin—Dizziness—Methotrexate—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Clindamycin—Rash—Methotrexate—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Clindamycin—Headache—Methotrexate—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Clindamycin—Nausea—Methotrexate—systemic scleroderma	0.00034	0.00034	CcSEcCtD
